Copiar e Editar

Psychopharmacology Exam #2 - Drug-Induced Movement Disorder

Descrição

Quiz sobre Psychopharmacology Exam #2 - Drug-Induced Movement Disorder, criado por Melanie Grynsztejn em 23-03-2018.
Melanie Grynsztejn
Quiz por Melanie Grynsztejn, atualizado more than 1 year ago
Melanie Grynsztejn
Criado por Melanie Grynsztejn mais de 6 anos atrás
49
1
0

Resumo de Recurso

Questão 1

Questão
The following are early onset EPS symptoms
Responda
  • Dystonia
  • Akathisia
  • Parkinsonism
  • Tardive dyskensia

Questão 2

Questão
Which EPS symtom can appear within days
Responda
  • Dystonia
  • Akatsia
  • Parkinsonism
  • Tardive dyskinesia

Questão 3

Questão
Which EPS symptom can appear within weeks?
Responda
  • Dystonia
  • Akathisia
  • Parkinsonsism
  • Tardive dyskenia

Questão 4

Questão
Which EPS symptom can appear within months?
Responda
  • Dystonia
  • Akathisia
  • Parkinsonism
  • Tardive dyskinesia

Questão 5

Questão
Which EPS symtoms can take years to appear?
Responda
  • Dystonia
  • Akathisia
  • Parkinsonism
  • Tardive dyskensia

Questão 6

Questão
Types of drug-induced movement disorders: [blank_start]Acute:[blank_end] Occur within a short duration of treatment onset or dose increase [blank_start]Chronic:[blank_end] Symptoms persist throughout treatment [blank_start]Tardive[blank_end]: Delayed onset of symptoms [blank_start]Withdrawal:[blank_end] Occur in the absence of treatment. May resolve
Responda
  • Acute:
  • Withdrawal:
  • Chronic:
  • Tardive
  • Tardive
  • Withdrawal
  • Withdrawal:
  • Tardive

Questão 7

Questão
Dopamine system pathways include: Mesolimbic: arousal, memory, behavior Mesocortical: cognition, socializaiont Tuberoinfundibular: regulation of prolactin Nigrostriatal: modulation of EPS
Image:
Dopamine Pathway (binary/octet-stream)
Responda
  • True
  • False

Questão 8

Questão
The mechanism for dystonia is
Image:
Dystonia (binary/octet-stream)
Responda
  • Dopamine deficiency in the basal ganglia and striatum
  • Overactive cholinergic system
  • Dopaminergic/serotonergic or dopaminergic/cholinergic imbalance in the nucleus accumbens
  • Blockade of the striatal dopamine receptors

Questão 9

Questão
What are risk factors for dystonia
Responda
  • Young age
  • H/O ECT
  • Male gender
  • High potency neuroleptics - Haldol, Prolixin
  • Comorbid medical conditions

Questão 10

Questão
Types of dystonia
Image:
Types Of Dystonia (binary/octet-stream)
Responda
  • Opisthotonos
  • Blepharospasm
  • Torticollis
  • Oculogyric crisis
  • Oro-mandibular

Questão 11

Questão
The MOA for akathisia, from the Greek meaning "inability to sit", is:
Responda
  • Dopamine deficiency in the basal ganglia and striatum
  • Dopaminergic/serotonergic or dopaminergic/cholinergic imbalance in the nucleus accumbens, Overstimulation of locus coeruleus.
  • Blockade of the striatal dopamine receptors
  • Striatal dopaminergic hypersensitivity

Questão 12

Questão
Which of the following agents cause akathisia
Responda
  • SSRI
  • Second generation antipsychotics
  • Antiemetics
  • CCB
  • Anti-anxiolytics

Questão 13

Questão
What are some differentials for akathisia
Responda
  • GAD
  • ADHD
  • Agitation
  • MDD

Questão 14

Questão
What are clinical presentation of akathisia
Responda
  • Restlessness
  • Breaking out into song & dance for no reason
  • Fidgety movements/leg swinging
  • Marching in place
  • Rocking from one foot to another
  • Picking

Questão 15

Questão
The risk factors for akathisia include
Responda
  • Advanced age
  • Affective disorder
  • Cognitive impairment
  • Female impersonator performer
  • Female
  • H/O akathisia
  • Iron deficiency
  • High dose/potency/neuroleptics

Questão 16

Questão
Pathophysiology of pseudoparkinsonism is:
Responda
  • Dopamine deficiency in the basal ganglia and striatum
  • Dopaminergic/serotonergic or dopaminergic/cholinergic imbalance in the nucleus accumbens
  • Blockade of the striatal dopamine receptors and depletion of pre-synaptic celft
  • Striatal dopaminergic hypersensitivity and cholinergic deficiency in the basal ganglia

Questão 17

Questão
Parkinsonism = [blank_start]bradykesia[blank_end] Pseudoparkinsonism = [blank_start]apraxic slowness[blank_end]
Responda
  • bradykesia
  • apraxic slowness
  • bradykinesia
  • apraxic slowness

Questão 18

Questão
Parkinsonism = [blank_start]resting tremor[blank_end] Pseudoparkinsonism = [blank_start]essential tremor, myoclonus[blank_end]
Responda
  • resting tremor
  • essential tremor, myoclonus
  • resting tremor
  • essential tremor, myoclonus

Questão 19

Questão
Parkinsonism = [blank_start]lead pipe rigidity[blank_end] Pseudoparkinsonism = [blank_start]paratonic rigidity[blank_end]
Responda
  • lead pipe rigidity
  • paratonic rigidity
  • lead pipe rigidity
  • paratonic rigidity

Questão 20

Questão
Parkinsonism = [blank_start]postural instability[blank_end] Pseudoparkinsonism = [blank_start]frontal ataxia[blank_end]
Responda
  • postural instability
  • frontal ataxia
  • postural instability
  • frontal ataxia

Questão 21

Questão
Parkinsonism = [blank_start]Slow, shuffling gait with festination[blank_end] Pseudoparkinsonism = [blank_start]Slow, shuffling apraxic gait[blank_end]
Responda
  • Slow, shuffling gait with festination
  • Slow, shuffling apraxic gait
  • Slow, shuffling gait with festination
  • Slow, shuffling apraxic gait

Questão 22

Questão
What are risk factors for pseudoparkinsonism?
Responda
  • Female
  • Male
  • Advanced age
  • Central DA receptor binding agents, Metclopramide, phenothiazines
  • AIDS
  • Cancer

Questão 23

Questão
Tardive dyskinesia
Responda
  • If identified early can be reversed
  • is not reversible
  • increased risk with increased use
  • increased use does not cause increases risk
  • early onset
  • late onset

Questão 24

Questão
MOA for tardive dyskinesia
Responda
  • Striatal dopaminergic hypersensitivity
  • Cholinergic deficiency within basal ganglia
  • Oxidative stress and cell injur
  • Genetic susceptibility
  • Glutamate-induced excitotoxicity
  • GABA mediated neuronal dysfunction
  • Blockade of the striatal dopamine receptors

Questão 25

Questão
Which medications most commonly cause tardive dyskinesia?
Responda
  • Meoclopramide
  • Alpha adrenergic agonists
  • SGA
  • FGA

Questão 26

Questão
Clinical presention of tardive dyskinesia
Responda
  • Choreiform - characterized by jerky, involuntary movements, chiefly of the face and extremities
    Image:
    Chorea (binary/octet-stream)
  • Athetoid - characterized by slow, involuntary, convoluted, writhing movements of the fingers, hands, toes, and feet and in some cases, arms, legs, neck and tongue
    Image:
    Atheosis (binary/octet-stream)
  • Stereotypic - petitive, nonfunctional motor behavior (e.g., hand waving or head banging), that markedly interferes with normal activities or results in bodily injury.
    Image:
    Stereotypic (binary/octet-stream)

Questão 27

Questão
EPS can be caused by antiemetics, antieliptics, psychotropics, cardiovascular agents and Levodopa
Image:
Movement (binary/octet-stream)
Responda
  • True
  • False

Questão 28

Questão
EPS can be caused by antiemetics, antieliptics, psychotropics, cardiovascular agents and Levodopa
Image:
Mediation1 (binary/octet-stream)
Responda
  • True
  • False

Questão 29

Questão
The following drugs cause all four movement disorders: dystonia, akathisia, Parkinsonism, tardive dyskinesia
Responda
  • Metoclopramide
  • Prochloraperazine
  • Amoxapine
  • Neuroleptics
  • SSRI
  • Levodopa

Questão 30

Questão
How often should the Abnormal Involuntary Movement Scale (AIMS) be administered?
Responda
  • Baseline then every week x4 then every 3 months
  • Baseline then every week x2 then every 12 months
  • Baseline then every week x2 then every 6 months

Questão 31

Questão
What are overall tips for treatment of EPS?
Responda
  • Stop offending agen (if possible)
  • Reduce the dose
  • Switch to a second generation antipsychotic
  • Treat prophylactically
  • A wing and prayer and refer to anyone else

Questão 32

Questão
Dystonia put in order of line of treatment First line = [blank_start]anticholinergic agents[blank_end] Second line = [blank_start]Baclofen[blank_end] Third line = [blank_start]Benzo[blank_end] Fourth line - [blank_start]Botox[blank_end]
Responda
  • anticholinergic agents
  • Baclofen
  • Benzo
  • Botox

Questão 33

Questão
This is a nice visual/review
Image:
Dystonia Treatment (binary/octet-stream)
Responda
  • True
  • False

Questão 34

Questão
Drug of choice for dystonia is
Responda
  • Beta-blockers, anticholinergics, benzodiazepines, 5-HT2A receptor antagonist, mirtazapine
  • Anticholinergics (benztropine, diphenhydramine, trihexyphenidyl)
  • Clonzaepam, ginkgo biloba

Questão 35

Questão
Drugs of choice for akathisia include
Responda
  • Anticholinergics (benztropine, diphenhydramine, trihexyphenidyl)
  • Beta-blockers, benzodiazepines, 5-HT2A receptor antagonist, mirtazapine
  • Clonazepam, ginkgo biloba

Questão 36

Questão
Mirtazapine (Remeron)
Responda
  • Used in low doses to treat akathisa
  • Used in low doses to treat dystonia
  • Alpha-adrenergic receptor antagonist
  • Alpha-adrenergic receptor agonist
  • Antagonizes 5-HT2 and 3 receptors

Questão 37

Questão
Visual for treatment of akathisia
Image:
Akathisa Algo (binary/octet-stream)
Responda
  • True
  • False

Questão 38

Questão
Which drugs are used to treat pseudoparkinsonism?
Responda
  • Cogentin (benztropine)
  • Symmetrel (amantadine)
  • Benzodiazepines
  • Mirtazapine (Remeron)
  • Diphenhydramine (Benadryl)

Questão 39

Questão
MOA for amantadine (Symmetrel) is
Responda
  • Dopamine agonist
  • Dopamine antagonist
  • 5-HT2 agonist
  • 5-HT2 antagonist

Questão 40

Questão
Side effects for benztropine (Cogentin) include
Responda
  • Dry mouth
  • Hypotension
  • Diarrhea
  • Constipation
  • Cognitive impairment
  • Sialorrhea

Questão 41

Questão
Side effects for amantadine (Symmetrel) include:
Responda
  • Hypotension
  • Hypertension
  • Agitation
  • Sedation
  • Worsening s/s of psychosis

Questão 42

Questão
Which drugs are used in the treatment of tardive dyskinesia
Responda
  • Diltiazem
  • Baclofen
  • Galantamine
  • Clonazepam
  • Ginkgo biloba

Questão 43

Questão
What is the first FDA approved medication for Tardive Dyskinesia
Responda
  • Velbeazine (Ingrezza)
  • Benztropine (Cogentin)
  • Trihexphenidyl (Artane)
  • Amantadine (Symmetrel)

Questão 44

Questão
What is the MOA for valbenazine (Ingrezza)?
Responda
  • Blocks alpha-adrenergic receptors and antagonizes 5-HT2 and 3 receptors
  • Reversible inhibition of vesicular monoamine transporter 2 (VMAT2), a transporter that regulates monoamine uptake from the cytoplasm to the synaptic vesicle for storage and release
  • Increase in synthesis and release of dopamine, and inhibition of dopamine uptake.
  • Selective M1 muscarinic acetylcholine receptor antagonist. It is able to discriminate between the M1 (cortical or neuronal) and the peripheral muscarinic subtypes (cardiac and glandular)

Questão 45

Questão
Acute [blank_start]laryngeal[blank_end] dystonia is considered a medical emergency. Must seek treatment immediately. May require IV diphenhydramine
Responda
  • laryngeal

Questão 46

Questão
Velbenazine is extensively metabolized by hydrolysis to form active metabolite and by oxidative metabolism to form mono-oxidized valbenazine and other minor metabolites
Responda
  • True
  • False

Questão 47

Questão
High fat meals may [blank_start]decrease[blank_end] absorption of valbenazine (Ingrezza)
Responda
  • decrease
  • increase

Questão 48

Questão
Common adverse side effects of valbenazine (Ingrezza) include:
Responda
  • Fatigue
  • HA
  • Constipation
  • Diarrhea
  • UTI
  • Somnolence

Questão 49

Questão
Warnings for valbenazine (Ingrezza) include:
Responda
  • Somnolence
  • QTc prolongation
  • Pregnancy/breastfeeding
  • Hypertension

Questão 50

Questão
Valbenazine should not be used in:
Responda
  • Severe renal impairment (< 30 mL/min)
  • CHF
  • Cirrhosis
  • Pancreatitis

Questão 51

Questão
Strong 3A4/2D6 inhibitors: [blank_start]Increase[blank_end] valbenazine concentration Strong 3A4 inducer: [blank_start]Decrease[blank_end] valbenazine concentration
Responda
  • Increase
  • Decrease
  • Increase
  • Decrease

Questão 52

Questão
Valbenazine (Ingrezza) interacts with MAOIs by [blank_start]increasing[blank_end] the monamine NT in the synapse
Responda
  • increasing
  • decreasing

Questão 53

Questão
Valbenazine (Ingrezza) interacts with digoxin and [blank_start]increase[blank_end]s the digoxin concentration by p-glycoprotein [blank_start]inhibtion[blank_end]
Responda
  • increase
  • decreases
  • inhibtion
  • inducer

Questão 54

Questão
Deutetrabenazine (Austedo) is used for the treatment of chorea and schizophrenia/schizoaffective disorder. It is metabolized by CYP2D6
Responda
  • True
  • False

Quer criar seus próprios Quizzes gratuitos com a GoConqr? Saiba mais.

Semelhante

Estudar para Exame da Ordem: 8 passos
Alessandra S.
Psicologia da Educação
rsgomes88
Progressão Aritmética (P.A.)
claudiac_
TEORIA DO DIREITO CONSTITUCIONAL #3
Eduardo .
METODOLOGIA E PRÁTICA DE ALFABETIZAÇÃO E LETRAMENTO
vanessasenez
EA-HSG-2011
carloshenriquetorrez .
Intertextualidade
Grazi_1
Guia de Estudos ENEM 2016
GoConqr suporte .
Plano de estudos ENEM - Parte 2 *Exatas/Biológicas
sarahnjife
Técnicas de Estudo Prof. Manoel Moraes
Luiz Fernando
TGA - Teoria Clássica
Natanael Lima
Explore a Biblioteca